Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases

Susceptibility and disease course of COVID-19 among patients with inflammatory bowel diseases (IBD) are unclear and epidemiological data on the topic are still limited. There is some concern that patients with immuno-mediated diseases such as IBD, which are frequently treated with immunosuppressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrias, Angelica, Cortes, Gian Mario, Bardanzellu, Flaminia, Melis, Alice, Fanos, Vassilios, Marcialis, Maria Antonietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468140/
https://www.ncbi.nlm.nih.gov/pubmed/34572185
http://dx.doi.org/10.3390/children8090753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468140/
https://www.ncbi.nlm.nih.gov/pubmed/34572185
http://dx.doi.org/10.3390/children8090753

Ejemplares similares